Volume 123, Issue 6, Pages (December 2002)

Slides:



Advertisements
Similar presentations
SIGNALING FROM THE CELL SURFACE TO THE NUCLEUS
Advertisements

IGF in circulation The majority (> 75 %) exists as bound form –IGF binding proteins (IGFBPs) IGFBPs –6 proteins and several related proteins –Serum IGFBP.
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Don C. Rockey  Clinical Gastroenterology and Hepatology 
The JAK-STAT signaling system represents a series of reactions that take place when a hormone binds a receptor that uses this system. While the hormone.
Leptin receptor functions: When leptin binds to its receptor (LEPR-B) the receptor undergoes a conformational change that activates the receptor-associated.
Biologic therapy of inflammatory bowel disease
Molecular regulation of mast cell activation
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
Complementary and alternative medicine: Herbs, phytochemicals and vitamins and their immunologic effects  Timothy Mainardi, MD, MS, Simi Kapoor, MD, Leonard.
Laurent L'homme, PhD, David Dombrowicz, PhD 
Miriam Marqués, Francisco X. Real  European Urology 
Volume 52, Issue 3, Pages (March 2010)
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Trachealess—A New Transcription Factor Target for PKB/Akt
Cell to Cell Communication via Enzyme Linked Receptors
Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease  Julián panés*, D.Neil Granger‡  Gastroenterology 
Biology of common β receptor–signaling cytokines
Dan Gordon  Gastroenterology  Volume 114, Issue 4, (April 1998)
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
Biologic therapy of inflammatory bowel disease
Robert K. Montgomery, Andrew E. Mulberg, Richard J. Grand 
Toll-like receptors in Borrelia burgdorferi-induced inflammation
Signaling molecules as therapeutic targets in allergic diseases
Tumor necrosis factor: Biology and therapeutic inhibitors
دکتر مجیری داروساز متخصص فارماکولوژی
Mechanisms of mast cell signaling in anaphylaxis
Molecular regulation of mast cell activation
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Is REDD1 a Metabolic Éminence Grise?
Epidermal growth factor receptor signaling
The Ying and Yang of Bacterial Signaling in Necrotizing Enterocolitis
The Genetics of Inflammatory Bowel Disease
Selective Insulin and Leptin Resistance in Metabolic Disorders
Met as a therapeutic target in HCC: Facts and hopes
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Trachealess—A New Transcription Factor Target for PKB/Akt
Volume 4, Issue 2, Pages (February 1996)
Volume 18, Issue 1, Pages (July 2013)
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again…
Antifibrotic therapy in chronic liver disease
Molecular Mechanisms Regulating Hair Follicle Development
Proteins Kinases: Chromatin-Associated Enzymes?
Molecular mechanisms of IgE regulation
SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide 
SRC and STAT Pathways Journal of Thoracic Oncology
Signalling links in the liver: Knitting SOCS with fat and inflammation
Masaaki Murakami, Daisuke Kamimura, Toshio Hirano  Immunity 
SOCS Proteins, Regulators of Intracellular Signaling
Manfred Fliegauf, PhD, Bodo Grimbacher, MD 
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
The suppressors of cytokine signaling (SOCS) proteins
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
NF-κB/Rel/IκB: Implications in gastrointestinal diseases
IL-13 receptors and signaling pathways: An evolving web
Shared Principles in NF-κB Signaling
GPC5 Gene and Its Related Pathways in Lung Cancer
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Figure 2 Signalling downstream of the IL-6 receptor
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Volume 119, Issue 4, Pages (October 2000)
Volume 7, Issue 1, Pages 1-11 (July 1997)
Tumor necrosis factor: Biology and therapeutic inhibitors
The canonical IFN-γ/JAK/STAT pathway.
UPR and cross-talk between apoptosis and metabolism.
Cell Signaling by Receptor Tyrosine Kinases
Characterization of the MM.1 human multiple myeloma (MM) cell lines
Overview of molecular JAK signaling.
Presentation transcript:

Volume 123, Issue 6, Pages 2064-2081 (December 2002) Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease  Christopher J. Greenhalgh, Megan E. Miller, Douglas J. Hilton, P.Kay Lund  Gastroenterology  Volume 123, Issue 6, Pages 2064-2081 (December 2002) DOI: 10.1053/gast.2002.37068 Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 1 Cytokines bind to specific sites on the extracellular domains of their cognitive receptor, causing receptor dimerization. This allows the recruitment of JAKs to the receptors, which then cross-phosphorylate each other before phosphorylating the receptor on key tyrosine residues. STAT molecules bind to these phosphorylated docking sites, are in turn phosphorylated, dimerize, and enter the nucleus where they initiate transcription. Some of the genes transcribed by these factors include the SOCS genes. The SOCS proteins then act to negatively regulate activated receptor complexes by inactivating JAKs or blocking recruitment sites for STATs and also may target signaling complexes for ubiquitination and degradation. Gastroenterology 2002 123, 2064-2081DOI: (10.1053/gast.2002.37068) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 2 Schematic of SOCS box containing proteins. The SOCS proteins are paired based on the highest amino acid homologies. The domain structures of each molecule is detailed. Gastroenterology 2002 123, 2064-2081DOI: (10.1053/gast.2002.37068) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 3 Model predicting the role of SOC-2 in GH-mediated proliferation and differentiation of intestinal epithelium. GH initially induces IGF-I, which stimulates crypt cell proliferation, but subsequent induction of SOCS-2 prevents sustained proliferation. SOCS-2 may impact on differentiation but this has not been examined definitively. Gastroenterology 2002 123, 2064-2081DOI: (10.1053/gast.2002.37068) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 4 Possible roles of SOCS in normal and diseased gastrointestinal tissue. ——|, Inhibitory effect; SOCS subtypes in parentheses are those implicated in particular events or cell types based on available evidence in cultured cells or mouse models. Cytokines at the bottom are those for which available evidence suggests that SOCS play a major role in their actions on specific gastrointestinal cell types. It is important to emphasize, however, that it seems likely that SOCS will play a role in the actions of a wider range of cytokines than indicated here. Gastroenterology 2002 123, 2064-2081DOI: (10.1053/gast.2002.37068) Copyright © 2002 American Gastroenterological Association Terms and Conditions